DexCom, Inc. (DXCM) financial statements and ratios from SEC XBRL: revenue $4.66B (TTM), net margin 17.9%, revenue growth 13.1% YoY, P/E 34.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.66B |
| Net Margin | 17.9% |
| Revenue Growth (YoY) | 13.1% |
| EPS Growth (YoY) | 41.3% |
| FCF Growth (YoY) | 64.6% |
| P/E Ratio | 34.1 |
| EV / EBITDA | 23.5 |
| Price / Book | 12.99 |
| Price / Sales | 6.85 |
| FCF Yield | 3.5% |
| DCF Value (model) | $53.77 |
| DCF Upside vs Price | -40.4% |
| Altman Z-Score | 7.90 (safe) |
| Sector P/E (Healthcare) | 21.6 |
DXCM overview · DXCM earnings · DXCM KPIs · DXCM investor relations · DXCM ownership · DXCM peers · DXCM filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.